Cargando…

Engineering a novel endopeptidase based on SARS 3CL(pro)

A 3C-like protease (3CL(pro)) from the severe acute respiratory syndrome–coronavirus (SARS-CoV) is required for viral replication, cleaving the replicase polyproteins at 11 sites with the conserved Gln↓(Ser, Ala, Gly) sequences. In this study, we developed a mutant 3CL(pro) (T25G) with an expanded S...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Chih-Jung, Shih, Yan-Ping, Kan, Daphne, Liang, Po-Huang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081961/
https://www.ncbi.nlm.nih.gov/pubmed/20041855
http://dx.doi.org/10.2144/000113303
_version_ 1783508262365167616
author Kuo, Chih-Jung
Shih, Yan-Ping
Kan, Daphne
Liang, Po-Huang
author_facet Kuo, Chih-Jung
Shih, Yan-Ping
Kan, Daphne
Liang, Po-Huang
author_sort Kuo, Chih-Jung
collection PubMed
description A 3C-like protease (3CL(pro)) from the severe acute respiratory syndrome–coronavirus (SARS-CoV) is required for viral replication, cleaving the replicase polyproteins at 11 sites with the conserved Gln↓(Ser, Ala, Gly) sequences. In this study, we developed a mutant 3CL(pro) (T25G) with an expanded S1′ space that demonstrates 43.5-fold better k(cat)/K(m) compared with wild-type in cleaving substrates with a larger Met at P1′ and is suitable for tag removal from recombinant fusion proteins. Two vectors for expressing fusion proteins with the T25G recognition site (Ala-Val-Leu-Gln↓Met) in Escherichia coli and yeast were constructed. Identical cloning sites were used in these vectors for parallel cloning. PstI was chosen as a 5′ cloning site because it overlapped the nucleotide sequence encoding the protease site and avoided addition of extra amino acids at the N terminus of recombinant proteins. 3CL(pro) (T25G) was found to have a 3-fold improvement over TEV(pro) in tag cleavage at each respective preferred cleavage site.
format Online
Article
Text
id pubmed-7081961
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Future Science Ltd
record_format MEDLINE/PubMed
spelling pubmed-70819612020-03-20 Engineering a novel endopeptidase based on SARS 3CL(pro) Kuo, Chih-Jung Shih, Yan-Ping Kan, Daphne Liang, Po-Huang Biotechniques Short Technical Reports A 3C-like protease (3CL(pro)) from the severe acute respiratory syndrome–coronavirus (SARS-CoV) is required for viral replication, cleaving the replicase polyproteins at 11 sites with the conserved Gln↓(Ser, Ala, Gly) sequences. In this study, we developed a mutant 3CL(pro) (T25G) with an expanded S1′ space that demonstrates 43.5-fold better k(cat)/K(m) compared with wild-type in cleaving substrates with a larger Met at P1′ and is suitable for tag removal from recombinant fusion proteins. Two vectors for expressing fusion proteins with the T25G recognition site (Ala-Val-Leu-Gln↓Met) in Escherichia coli and yeast were constructed. Identical cloning sites were used in these vectors for parallel cloning. PstI was chosen as a 5′ cloning site because it overlapped the nucleotide sequence encoding the protease site and avoided addition of extra amino acids at the N terminus of recombinant proteins. 3CL(pro) (T25G) was found to have a 3-fold improvement over TEV(pro) in tag cleavage at each respective preferred cleavage site. Future Science Ltd 2009-12 2009-04-25 /pmc/articles/PMC7081961/ /pubmed/20041855 http://dx.doi.org/10.2144/000113303 Text en © 2009 Author(s) This work is licensed under the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/)
spellingShingle Short Technical Reports
Kuo, Chih-Jung
Shih, Yan-Ping
Kan, Daphne
Liang, Po-Huang
Engineering a novel endopeptidase based on SARS 3CL(pro)
title Engineering a novel endopeptidase based on SARS 3CL(pro)
title_full Engineering a novel endopeptidase based on SARS 3CL(pro)
title_fullStr Engineering a novel endopeptidase based on SARS 3CL(pro)
title_full_unstemmed Engineering a novel endopeptidase based on SARS 3CL(pro)
title_short Engineering a novel endopeptidase based on SARS 3CL(pro)
title_sort engineering a novel endopeptidase based on sars 3cl(pro)
topic Short Technical Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081961/
https://www.ncbi.nlm.nih.gov/pubmed/20041855
http://dx.doi.org/10.2144/000113303
work_keys_str_mv AT kuochihjung engineeringanovelendopeptidasebasedonsars3clpro
AT shihyanping engineeringanovelendopeptidasebasedonsars3clpro
AT kandaphne engineeringanovelendopeptidasebasedonsars3clpro
AT liangpohuang engineeringanovelendopeptidasebasedonsars3clpro